Nurse Intervention Trial
Key facts
- Who runs it
- Norwegian University of Science and Technology
- Where
- Norway1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Terminated
- People taking part
- 147 people enrolled
- Started
- 21 Apr 2023
- Ended
- 31 Jan 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Telephone by nurse
- Record updated
- 13 April 2026
- Why it stopped
- Based on ethical considerations arising from the interim analyses, the study was terminated before the planned sample size of 400 participants was reached
Who can take part
- Age
- 18 years to 90 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- One of the following headache diagnoses based on the International Classification of Headache Disorders, third edition (ICDH3): G44.2 Chronic tension-type headache and/or G43 Episodic and chronic migraine, G44.0 Episodic and chronic cluster headache, G44.8 Hemicrania Continua
- Indication for preventive medication where there is at least one alternative with the need for follow-up assessment of effectiveness
Who cannot take part
- Treatment with Onabotulinumtoxin A or Calcitonin-gene-related Peptide (CGRP) inhibitors given with three months intervals
- Need treatment of other comorbid conditions requiring follow-up in specialized healthcare
- Uncertain headache diagnosis
- Need further investigation after the initial consultation
- Lack of understanding of information provided in Norwegian, both verbally and in writing
- Inability to keep a digital headache diary
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This randomized open-label prospective study focus on headache patients initiating preventive treatment, where the treating physician identifies a need for follow-up visits in specialized healthcare. The study will clarify whether the implementation (compliance) and overall satisfaction of the patient are better with follow-up by a headache nurse compared to standard follow-up. Patients with signed written consent will be randomised to either group a: Telephone calls from nurse after two and 6 week or B. Patient-initiated follow-up by their general practitioner.
The 2 groups in the trial
- Telephone by nurseExisting treatment, for comparison
The headache patients will be contacted by nurse by phone after approximately 2 week and 6 week after start of preventive medical treatment. The patient will have a follow-up visit by neurologist after 3 months.
- Patient-initiated follow-upNo study treatment, for comparison
The headache patient contact their general practitioner (GP) and/or the neurologist by a study-specific email if they have questions regarding the preventive medical treatment
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Nurse Intervention Trial: The Evaluation of Usefulness of a Headache Nurse
- Record updated
- 13 April 2026